Shanghai launches IPR complaints center

30 April 2006

A dedicated one-stop shop for intellectual property rights complaints is to open in China's major business center, Shanghai, according to local media reports. The agency will receive complaints and process them through the relevant administrations.

Liu Minhong, a divisional chief of the Shanghai Intell-ectual Property Administration, told the Shanghai Daily newspaper: "it will offer more convenience to IPR owners because they can lodge complaints no matter what. Other-wise, IPR owners must first know what kind of violations are involved and approach different departments because each has its own specialty."

President Hu Jintao's recent visit to the USA raised the issue of IPR, with the US government pressing Chinese authorities to do more to crack down on counterfeiting, including pharmaceutical products.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight